Oportun Financial (OPRT) Receives a Hold from JMP Securities
In a report released today, David Scharf from JMP Securities maintained a Hold rating on Oportun Financial (OPRT – Research Report). The ...
Jazz Pharmaceuticals upgraded to Overweight from Equal Weight at Wells Fargo
Wells Fargo analyst Mohit Bansal upgraded Jazz Pharmaceuticals (JAZZ) to Overweight from Equal Weight with a price target of $170, up from ...
Gilead price target raised to $120 from $105 at Wells Fargo
Wells Fargo analyst Mohit Bansal raised the firm’s price target on Gilead (GILD) to $120 from $105 and keeps an Overweight rating on the ...
Wells bullish on Travere Therapeutics, sees 30% of upside on submission plans
Wells Fargo analyst Mohit Bansal notes Travere Therapeutics (TVTX) plans to submit on Phase 3 DUPLEX study after FDA meeting. The company plans ...